N-myc downstream-regulated gene 1 as a downregulated target gene of PTEN in the controlling of tumourigenesis in endometrioid carcinoma

Indian Journal of Medical Research

Volumn 127, Issue 5, 2008, Pages 453-459

  Li, Shuxia ^a   Chen, Jiawei ^a   Yang, Zhaorui ^a   Lu, Guangzhong ^a   Tang, Huamei ^a   Hu, Honghui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Endometroid carcinoma; NDRG1; PTEN

Indexed keywords

N MYC DOWNSTREAM REGULATED PROTEIN 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN DERIVATIVE;

AGE DISTRIBUTION; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; TISSUE NECROSIS; UPREGULATION;

CARCINOMA, ENDOMETRIOID; CELL CYCLE PROTEINS; ENDOMETRIUM; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; PTEN PHOSPHOHYDROLASE;

EID: 51349097817     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Amant F, Moerman P, Neve. P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005; 366: 491-505.
2. St-Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int J Oncol 2004; 24: 1311-24.
3. Kanamori Y, Kigawa J, Itamochi H, Shimada M, Takahashi M, Kamazawa S, et al. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin Cancer Res 2001; 7: 892-5.
4. Wan X, Yokoyama Y, Shinohara A, Takahashi Y, Tamaya T. PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway. Cell Death Differ 2002; 9: 414-20.
5. Li YM, Zhou BP, Deng J, Pan Y, Hay N, Hung MC. A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells. Cancer Res 2005; 65: 3257-63.
6. Bardos JI, Chau NM, Ashcroft M. Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor I alpha expression. Mol Cell Biol 2004; 24: 2905-14.
7. Li J, Davidson G, Huang Y, Jiang BH, Shi X, Costa M, et al. Nickel compounds act through phosphatidylinositol-3-kinase/Akt-dependent, p70S6k-independent pathway to induce hypoxia inducible factor transactivation and Cap43 expression in mouse epidermal C141 cells. Cancer Res 2004; 64: 94-101.
8. Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000; 14: 391-6.
9. Gomez-Manzano C, Fueyo J, Jiang H, Glass TL, Lee HY, Hu M, et al. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Ann Neurol 2003; 53: 109-17.
10. Li L, He F, Litofsky NS, Recht LD, Ross AH. Profiling of genes expressed by PTEN haploinsufficient neural precursor cells. Mol Cell Neurosci 2003; 24: 1051-61.
11. Natarajan R, Fisher BJ, Fowler AA 3rd. Regulation of hypoxia inducible factor-1 by nitric oxide in contrast to hypoxia in microvascular endothelium. FEBS Lett 2003; 549: 99-104.
12. Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, et al. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res 2004; 64: 7655-60.
13. Salnikow K, Davidson T, Zhang Q, Chen LC, Su W, Costa M. The Involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis. Cancer Res 2003; 63: 3524-30.
14. Park H, Adams MA, Lachat P, Bosman F, Pang SC, Graham CH. Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. Biochem Biophys Res Commun 2000; 276: 321-8.
15. Salnikow K, Blagosklonny MV, Ryan H, Johnson R, Costa M. Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res 2000; 60: 38-41.
16. Cangul H. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 2004; 5: 27.
17. Salnikow K, Kluz T, Costa M, Piquemal D, Demidenko ZN, Xie K, et al. The regulation of hypoxic genes by calcium involves c-Jun/AP-I, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol Cell Biol 2002; 22: 1734-41.
18. Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M. Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis. Cell Biol Toxicol 2002; 18: 87-96.
19. Salnikow K, Davidson T, Costa M. The role of hypoxia-inducible signaling pathway in nickel carcinogcnesis. Environ Health Perspect 2002; 110 (Suppl 5): S831-4.
20. Tarvassoli FA, Devilee P, editors. World Health Organization Classification of tumours. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press; 2003.
21. Raleigh JA, Calkins-Adams DP, Rinker LH, Ballenger CA, Weissler MC, Fowler WC Jr. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker1. Cancer Res 1998; 58: 3765-8.
22. Baak JP, Van Diermen B, Steinbakk A, Janssen E, Skaland I, Mutter GL, et al. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression. Hum Pathol 2005; 36: 555-61.
23. Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 2001; 93: 1337-43.
24. Sun H, Enomoto T, Fujita M, Wada H, Yoshino K, Ozaki K, et al. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia J. Am J Clin Pathol 2001; 115: 32-8.
25. Tashiro H, Blazes MS, Wit R, Cho KR, Bose S, Wang SI, et al. Mutations in PTEA are frequent in endometrial carcinoma but rare in other common gynecological malignances. Cancer Res 1997; 57: 3935-40.
26. Minaguchi T, Yoshikawa H, Oda K, Ishino T, Yasugi T, Onda T, et al. PTEN mutation located only outside exons 5, 6 and 7 is an independent predictor of favorable survival in endometrial carcinomas. Clin Cancer Res 2001; 7: 2636-42.